GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EQL Pharma AB (FRA:7JK) » Definitions » Shiller PE Ratio

EQL Pharma AB (FRA:7JK) Shiller PE Ratio : 123.67 (As of May. 26, 2024)


View and export this data going back to 2021. Start your Free Trial

What is EQL Pharma AB Shiller PE Ratio?

As of today (2024-05-26), EQL Pharma AB's current share price is €3.71. EQL Pharma AB's E10 for the quarter that ended in Mar. 2024 was €0.03. EQL Pharma AB's Shiller PE Ratio for today is 123.67.

The historical rank and industry rank for EQL Pharma AB's Shiller PE Ratio or its related term are showing as below:

FRA:7JK' s Shiller PE Ratio Range Over the Past 10 Years
Min: 89.31   Med: 120   Max: 180.48
Current: 117.05

During the past years, EQL Pharma AB's highest Shiller PE Ratio was 180.48. The lowest was 89.31. And the median was 120.00.

FRA:7JK's Shiller PE Ratio is ranked worse than
94.58% of 535 companies
in the Drug Manufacturers industry
Industry Median: 24.25 vs FRA:7JK: 117.05

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

EQL Pharma AB's adjusted earnings per share data for the three months ended in Mar. 2024 was €0.014. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is €0.03 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


EQL Pharma AB Shiller PE Ratio Historical Data

The historical data trend for EQL Pharma AB's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EQL Pharma AB Shiller PE Ratio Chart

EQL Pharma AB Annual Data
Trend Dec14 Dec15 Dec16 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 178.18 104.90

EQL Pharma AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 178.18 126.52 92.12 96.38 104.90

Competitive Comparison of EQL Pharma AB's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, EQL Pharma AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EQL Pharma AB's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, EQL Pharma AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where EQL Pharma AB's Shiller PE Ratio falls into.



EQL Pharma AB Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

EQL Pharma AB's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=3.71/0.03
=123.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EQL Pharma AB's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, EQL Pharma AB's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.014/132.2054*132.2054
=0.014

Current CPI (Mar. 2024) = 132.2054.

EQL Pharma AB Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -0.022 99.788 -0.029
201406 -0.018 100.432 -0.024
201409 -0.013 100.161 -0.017
201412 -0.011 100.225 -0.015
201503 0.004 99.950 0.005
201506 0.004 99.995 0.005
201509 0.008 100.228 0.011
201512 0.004 100.276 0.005
201603 0.015 100.751 0.020
201606 0.000 101.019 0.000
201609 0.000 101.138 0.000
201612 -0.001 102.022 -0.001
201703 0.000 102.022 0.000
201706 -0.001 102.752 -0.001
201709 0.003 103.279 0.004
201803 0.000 103.962 0.000
201806 0.000 104.875 0.000
201809 0.004 105.679 0.005
201812 -0.006 105.912 -0.007
201903 -0.003 105.886 -0.004
201906 0.000 106.742 0.000
201909 0.004 107.214 0.005
201912 0.005 107.766 0.006
202003 0.001 106.563 0.001
202006 0.037 107.498 0.046
202009 0.011 107.635 0.014
202012 0.007 108.296 0.009
202103 -0.021 108.360 -0.026
202106 0.009 108.928 0.011
202109 0.027 110.338 0.032
202112 0.057 112.486 0.067
202203 0.022 114.825 0.025
202206 0.024 118.384 0.027
202209 0.046 122.296 0.050
202212 0.036 126.365 0.038
202303 0.012 127.042 0.012
202306 0.020 129.407 0.020
202309 0.033 130.224 0.034
202312 0.020 131.912 0.020
202403 0.014 132.205 0.014

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


EQL Pharma AB  (FRA:7JK) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


EQL Pharma AB Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of EQL Pharma AB's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


EQL Pharma AB (FRA:7JK) Business Description

Traded in Other Exchanges
Address
Stortorget 1, 3rd Floor, Lund, SWE, 222 23
EQL Pharma AB is a pharmaceutical company engaged in developing and selling medicines to pharmacies and hospitals. The products offered by the company include generics and parallel imports. It operates and markets products to Nordic countries of Sweden, Denmark, Finland and Norway.

EQL Pharma AB (FRA:7JK) Headlines

No Headlines